Team:Freiburg/Project
From 2008.igem.org
m |
m |
||
(16 intermediate revisions not shown) | |||
Line 13: | Line 13: | ||
As controllable receptor activation event, we chose spatial control of dimerization, which is a mechanism often used by nature. To achieve spatial control in the nanometer range we chose DNA origami for exact and complex patterns with several ligands and we opted for chemical coupling of one type of ligand to a scaffold protein for simple multimerization.<br> | As controllable receptor activation event, we chose spatial control of dimerization, which is a mechanism often used by nature. To achieve spatial control in the nanometer range we chose DNA origami for exact and complex patterns with several ligands and we opted for chemical coupling of one type of ligand to a scaffold protein for simple multimerization.<br> | ||
- | To facilitate binding, we used a single-chain Fv antibody fragment and a designed anticalin. Both bind haptens (nitro-jodo-phenol and fluorescein) which can be conjugated to specific oligonucleotides of the DNA | + | To facilitate binding, we used a single-chain Fv antibody fragment and a designed anticalin. Both bind haptens (nitro-jodo-phenol and fluorescein) which can be conjugated to specific oligonucleotides of the DNA origami or scaffold proteins. Transduction to the cytosol is mediated by a single transmembrane helix taken either from the EGF-receptor or B-cell-receptor.<br> |
As intracellular reporters we employ split proteins. Here, we used the split lactamase from the iGEM2007 Freiburg project as well as the split fluorescent proteins CFP/cerulean and YFP/venus. To provide steric flexibility and reach of our binding and reporting modules we interspersed linkers between each functional domain.<br> | As intracellular reporters we employ split proteins. Here, we used the split lactamase from the iGEM2007 Freiburg project as well as the split fluorescent proteins CFP/cerulean and YFP/venus. To provide steric flexibility and reach of our binding and reporting modules we interspersed linkers between each functional domain.<br> | ||
Line 19: | Line 19: | ||
All parts submitted feature full BioBrick compatibility and in addition allow for the construction of fusion proteins due to extended Biobrick 3.0 (Freiburg) standard. Cloning was done in <i>E. coli</i>. However, we test our receptors in human or mouse cells/chassis. Thus, to direct our constructs to the cell surface we attached a eukaryotic signal peptide taken from hEGF-R to the N-terminus of each synthetic receptor. In addition to our designed synthetic receptors, we initially also employed an existing T-cell line.<br> | All parts submitted feature full BioBrick compatibility and in addition allow for the construction of fusion proteins due to extended Biobrick 3.0 (Freiburg) standard. Cloning was done in <i>E. coli</i>. However, we test our receptors in human or mouse cells/chassis. Thus, to direct our constructs to the cell surface we attached a eukaryotic signal peptide taken from hEGF-R to the N-terminus of each synthetic receptor. In addition to our designed synthetic receptors, we initially also employed an existing T-cell line.<br> | ||
- | To reach our goal within the short given time frame we started several subprojects in parallel. Our subprojects listed here are defined along these projects. Besides designing and cloning parts we spent quite some time on establishing and analyzing the biological experiments. Initially we tested interfacing of DNA origami with cells and the spatial control via DNA origami using the existing T-cell line expressing the scFv fused to a T-cell receptor. For T-cell receptor experiments we used | + | To reach our goal within the short given time frame we started several subprojects in parallel. Our subprojects listed here are defined along these projects. Besides designing and cloning parts we spent quite some time on establishing and analyzing the biological experiments. Initially we tested interfacing of DNA origami with cells and the spatial control via DNA origami using the existing T-cell line expressing the scFv fused to a T-cell receptor. For T-cell receptor experiments we used Ca<sup>2+</sup> signaling as read out. Synthetic receptor activation was analyzed using the formation of fluorescent proteins or turnover of a fluorescent lactamase substrate. In our experiments we addressed the following questions:<br> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | In our modeling analyses we constructed various sets of differential equations | + | * Can we design DNA origami to induce receptor multimerization?<br> |
+ | * Can we improve DNA origami assembly yield by varying the staple oligonucleotide to scaffold DNA ratio?<br> | ||
+ | * Can we find buffer conditions, which mediate cell viability and origami stability?<br> | ||
+ | * Can we downsize a Ca<sup>2+</sup> release assay to fit the sample sizes of our precious DNA origami?<br> | ||
+ | * Do our constructs express and then localize in the membrane of eukaryotic cells?<br> | ||
+ | * Do DNA origamis bind to cells?<br> | ||
+ | * Can we detect synthetic receptor activation?<br> | ||
+ | |||
+ | In short, we successfully addressed the first six questions. Experiments to demonstrate synthetic receptor activation are ongoing. | ||
+ | |||
+ | For our modeling analyses we constructed various sets of differential equations describing our synthetic receptors and predicted split protein activation behaviour. | ||
The labs of Kristian Müller and Katja Arndt provided all basic technology and support to get started. For advanced analyses several labs of the University of Freiburg and the Max-Planck-Institute of Immunobiology granted access to their instrumentation (e.g. atomic force micoscopy, confocal microscopy, FACS). | The labs of Kristian Müller and Katja Arndt provided all basic technology and support to get started. For advanced analyses several labs of the University of Freiburg and the Max-Planck-Institute of Immunobiology granted access to their instrumentation (e.g. atomic force micoscopy, confocal microscopy, FACS). | ||
Line 35: | Line 38: | ||
<br><br> | <br><br> | ||
<h2>'''Subprojects'''</h2> | <h2>'''Subprojects'''</h2> | ||
- | [[Team:Freiburg/Modeling|Modeling]]<br> | + | *[[Team:Freiburg/Modeling|Modeling]]<br> |
- | [[Team:Freiburg/3D-Modeling|3D-Modeling]]<br> | + | *[[Team:Freiburg/3D-Modeling|3D-Modeling]]<br> |
- | [[DNA-Origami|DNA-Origami]]<br> | + | *[[DNA-Origami|DNA-Origami]]<br> |
- | [[Team:Freiburg_Cloning Strategy|Cloning Strategy]]<br> | + | *[[Team:Freiburg_Cloning Strategy|Cloning Strategy]]<br> |
- | [[Team:Freiburg_Transfection and Synthetic Receptor|Transfection and Synthetic Receptor Activation]]<br> | + | *[[Team:Freiburg_Transfection and Synthetic Receptor|Transfection and Synthetic Receptor Activation]]<br> |
- | [[Team:Freiburg_Calcium Imaging|Cell Stability, Ca<sup>2+</sup> Signaling and DNA-Origami-Binding]]<br><br> | + | *[[Team:Freiburg_Calcium Imaging|Cell Stability, Ca<sup>2+</sup> Signaling and DNA-Origami-Binding]]<br><br> |
<h2>'''Highlights'''</h2> | <h2>'''Highlights'''</h2> | ||
Line 50: | Line 53: | ||
<!-- Dimerization of extracellular receptor domains is an important necessity for the functionality of our Modular Synthetic Receptor System. Presenting the system a stimulus in form of spatially arranged ligands (nitro-iodo-phenol or fluorescein molecules) results in dimerization and thus the corresponding intracellular parts such as the split lactamase halves or split fluorescent proteins complement to measureable output. --> | <!-- Dimerization of extracellular receptor domains is an important necessity for the functionality of our Modular Synthetic Receptor System. Presenting the system a stimulus in form of spatially arranged ligands (nitro-iodo-phenol or fluorescein molecules) results in dimerization and thus the corresponding intracellular parts such as the split lactamase halves or split fluorescent proteins complement to measureable output. --> | ||
- | Receptor dimerization and activation was analyzed by introducing and discussing two receptor dimerization models | + | Receptor dimerization and activation was analyzed by introducing and discussing two receptor dimerization models: One T cell receptor model and one general receptor model. A proper model for the Modular Synthetic Receptor System was constructed. It consists of 10 reaction kinetic equations, 9 ordinary differential equations including 25 variable parameters. Matlab m-files are embedded for further inspection. |
</td> | </td> | ||
<td> | <td> | ||
Line 61: | Line 64: | ||
<tr> | <tr> | ||
<td> | <td> | ||
- | [[Image:Team-Freiburg2008_Lipo_alpha_nCFP.png|thumb|left|250 px| | + | [[Image:Team-Freiburg2008_Lipo_alpha_nCFP.png|thumb|left|250 px|Structural model of expression part Bba_K157037]] |
</td> | </td> | ||
<td> | <td> | ||
<h4>[[Team:Freiburg/3D-Modeling|3D-Modeling]]</h4> | <h4>[[Team:Freiburg/3D-Modeling|3D-Modeling]]</h4> | ||
- | We have created various three-dimensional models of our constructs using Pymol and SwissPdbViewer. Pdb-files of the huge DNA-Origami molecule were created as adequate as possible using Nano-Engineer | + | We have created various three-dimensional models of our constructs using Pymol and SwissPdbViewer. Pdb-files of the huge DNA-Origami molecule were created as adequate as possible using Nano-Engineer V1.0 and then edited in Pymol. These Models were used to plan the spatial arrangement and, thus, input-pattern of antigens at a nanometer scale.<br><br><br> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 85: | Line 88: | ||
<tr> | <tr> | ||
<td> | <td> | ||
- | [[Image:Freiburg2008 Konstrukte.jpg|thumb|left|250px| | + | [[Image:Freiburg2008 Konstrukte.jpg|thumb|left|250px|Cloning scheme]] |
</td> | </td> | ||
<td> | <td> | ||
<h4>[[Team:Freiburg_Cloning Strategy|Cloning Strategy]]</h4> | <h4>[[Team:Freiburg_Cloning Strategy|Cloning Strategy]]</h4> | ||
All of our constructs were cloned successfully using our extended pre- and suffix and plasmid "pMA" (part [http://partsregistry.org/wiki/index.php?title=Part:BBa_K157000 Bba_K157000]). The broad combinatorial range given by the modular concept was almost fully exploited, so that we ended up with the submission of 13 basic and 28 composite parts.<br> | All of our constructs were cloned successfully using our extended pre- and suffix and plasmid "pMA" (part [http://partsregistry.org/wiki/index.php?title=Part:BBa_K157000 Bba_K157000]). The broad combinatorial range given by the modular concept was almost fully exploited, so that we ended up with the submission of 13 basic and 28 composite parts.<br> | ||
- | Once a construct was completed, it was cloned into the CMV-promoted transfection vector (part Bba_K157040) and used for transfection of 293T-cells.<br> | + | Once a construct was completed, it was cloned into the CMV-promoted transfection vector (part [http://partsregistry.org/wiki/index.php?title=Part:BBa_K157000 Bba_K157040]) and used for transfection of 293T-cells.<br> |
</td> | </td> | ||
</tr> | </tr> | ||
Line 100: | Line 103: | ||
<h4>[[Team:Freiburg_Transfection and Synthetic Receptor|Transfection and Synthetic Receptor Activation]]</h4> | <h4>[[Team:Freiburg_Transfection and Synthetic Receptor|Transfection and Synthetic Receptor Activation]]</h4> | ||
Transfection of 293T-cells has been shown to work for most of our fusion proteins; so far, we could even show that at least our constructs with lipocalin FluA as extracellular domaine are integrated into the membrane.<br> | Transfection of 293T-cells has been shown to work for most of our fusion proteins; so far, we could even show that at least our constructs with lipocalin FluA as extracellular domaine are integrated into the membrane.<br> | ||
- | All transfections were carried out with part Bba_K157040, one of our composite parts consisting of the transfection vector Bba_J52017 and a CMV-promotor. Due to the limited time range we were not yet able to demonstrate activation of the various possible "receptor"-pairs, but we are hoping to receive a positive result soon.<br> | + | All transfections were carried out with part [http://partsregistry.org/wiki/index.php?title=Part:BBa_K157040 Bba_K157040], one of our composite parts consisting of the transfection vector Bba_J52017 and a CMV-promotor. Due to the limited time range we were not yet able to demonstrate activation of the various possible "receptor"-pairs, but we are hoping to receive a positive result soon.<br> |
</td> | </td> | ||
<td> | <td> | ||
- | [[Image:Freiburg2008_Fluomembrane.jpg|thumb|right|200px| | + | [[Image:Freiburg2008_Fluomembrane.jpg|thumb|right|200px|Membrane-localization of Part Bba_K157032-YFP]] |
</td> | </td> | ||
</tr> | </tr> | ||
Line 111: | Line 114: | ||
<tr> | <tr> | ||
<td> | <td> | ||
- | [[Image:TeamFreiburg2008_Pervanadate1.png|thumb|left|200px|Ca-influx measurement]] | + | [[Image:TeamFreiburg2008_Pervanadate1.png|thumb|left|200px|Ca<sup>2+</sup>-influx measurement]] |
</td> | </td> | ||
<td> | <td> | ||
Line 126: | Line 129: | ||
<h2>'''[[Image:MO2.jpg|50px|]]Literature'''</h2> | <h2>'''[[Image:MO2.jpg|50px|]]Literature'''</h2> | ||
'''Split-fluorophores:'''<br> | '''Split-fluorophores:'''<br> | ||
- | + | *Chang-Deng Hu, Yurii Chinenov, Tom K. Kerppola: ”Visualization of Interactions among bZIP and Rel Family Proteins in Living Cells Using Bimolecular Fluorescence Complementation”, Molecular Cell, Vol. 9, 789–798, April, 2002<br> | |
- | + | *Chang Deng Hu, Tom K. Kerppola: “Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis”, Nat Biotechnol. 2003 May; 21(5):539-545 (doi:10. 1038/nbt816)<br> | |
- | + | *Tom K. Kerppola: “Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells”, Nat Protoc. 2006;1(3):1278-1286 (doi:10.1038/nprot.2006.201)<br> | |
- | + | *Nagai, T. et al. “A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications” J. Biol. Chem. 276, 29188-29194, 2001<br> | |
- | + | *Roger Y. Tsien et al. „Creating new fluorescent probes for cell biology“, Nature Biotechnology Reviews, Vol. 3, 906-918, 2002<br> | |
'''LipocalinFluA:'''<br> | '''LipocalinFluA:'''<br> | ||
- | + | *Gerald Beste, Frank S. Schmidt, Thomas Stibora and A. Skerra: “Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold“,Proc. Natl. Acad. Sci. USA Vol. 96, pp. 1898–1903, March 1999 Biochemistry<br> | |
- | + | *Ingo P. Korndörfer, Gerald Beste and A. Skerra: “Crystallographic Analysis of an “Anticalin” With Tailored Specificity for Fluorescein Reveals High Structural Plasticity of the Lipocalin Loop Region”, PROTEINS: Structure, Function, and Bioinformatics 53:121–129 (2003)<br> | |
'''DNA-Origami:'''<br> | '''DNA-Origami:'''<br> | ||
- | Paul W. K. Rothemund: "Folding DNA to create nanoscale shapes and patterns", Nature 440, 297-302 (16 March 2006)<br> | + | *Paul W. K. Rothemund: "Folding DNA to create nanoscale shapes and patterns", Nature 440, 297-302 (16 March 2006)<br> |
'''Antibody B1-8:'''<br> | '''Antibody B1-8:'''<br> | ||
- | + | *Ana Cumano and Klaus Rajewski: “Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP”, The EMBO Journal vol. 5 no.10 pp. 2459-2468, 1986<br> | |
- | + | *D. Allen, T. Simon, F. Sablitzky, K. Rajewski and A. Cumano: “Antibody engineering for the analysis of affinity maturation of an anti-hapten response”, The EMBO Journal vol. 7 no.7 pp. 1995-2001, 1988<br> | |
'''Modeling:'''<br> | '''Modeling:'''<br> | ||
- | + | *Martin F. Bachmann, Michael Salzmann, Annette Oxenius and Pamela S. Ohashi: "Formation of TCR dimers/trimers as a crucial step for T cell activation", Eur. J. Immunol., 1998<br> | |
- | + | *Martin F. Bachmann and Pamela S. Ohashi: "The role of T-cell receptor dimerization in T-cell activation", Review Immunology Today, 1999<br> | |
- | + | *João Sousa and Jorge Carneiro: "A mathematical analysis of TCR serial triggering and down-regulation", Eur. J. Immunol., 2000<br> | |
'''TCR activation:'''<br> | '''TCR activation:'''<br> | ||
- | + | *Susana Minguet, Mahima Swamy, Balbino Alarcón, Immanuel F. Luescher and Wolfgang W.A. Schamel: "Full Activation of the T Cell Receptor requires Both Clustering and Conformational Changes at CD3", Immunity, 2006 | |
}} | }} |
Latest revision as of 08:24, 30 October 2008
Project Report |
_project report
SummaryModular Synthetic Receptor System In the following we provide a summary of our project and display the highlights of our achievements. For a more detailed view please see the reports of each subproject. The general goal of the Freiburg 2008 team is to establish a synthetic transmembrane receptor system comprising the extracellular input devices, the extracellular receiver domain, the transducer to the cytosol and the reporter/executor in the cytosol. To facilitate binding, we used a single-chain Fv antibody fragment and a designed anticalin. Both bind haptens (nitro-jodo-phenol and fluorescein) which can be conjugated to specific oligonucleotides of the DNA origami or scaffold proteins. Transduction to the cytosol is mediated by a single transmembrane helix taken either from the EGF-receptor or B-cell-receptor. As intracellular reporters we employ split proteins. Here, we used the split lactamase from the iGEM2007 Freiburg project as well as the split fluorescent proteins CFP/cerulean and YFP/venus. To provide steric flexibility and reach of our binding and reporting modules we interspersed linkers between each functional domain. All parts submitted feature full BioBrick compatibility and in addition allow for the construction of fusion proteins due to extended Biobrick 3.0 (Freiburg) standard. Cloning was done in E. coli. However, we test our receptors in human or mouse cells/chassis. Thus, to direct our constructs to the cell surface we attached a eukaryotic signal peptide taken from hEGF-R to the N-terminus of each synthetic receptor. In addition to our designed synthetic receptors, we initially also employed an existing T-cell line. To reach our goal within the short given time frame we started several subprojects in parallel. Our subprojects listed here are defined along these projects. Besides designing and cloning parts we spent quite some time on establishing and analyzing the biological experiments. Initially we tested interfacing of DNA origami with cells and the spatial control via DNA origami using the existing T-cell line expressing the scFv fused to a T-cell receptor. For T-cell receptor experiments we used Ca2+ signaling as read out. Synthetic receptor activation was analyzed using the formation of fluorescent proteins or turnover of a fluorescent lactamase substrate. In our experiments we addressed the following questions:
In short, we successfully addressed the first six questions. Experiments to demonstrate synthetic receptor activation are ongoing. For our modeling analyses we constructed various sets of differential equations describing our synthetic receptors and predicted split protein activation behaviour. The labs of Kristian Müller and Katja Arndt provided all basic technology and support to get started. For advanced analyses several labs of the University of Freiburg and the Max-Planck-Institute of Immunobiology granted access to their instrumentation (e.g. atomic force micoscopy, confocal microscopy, FACS).
Subprojects
Highlights
|